A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
Category: Health Insurance and Managed Care
-
Health Tips for International Travel: What to Know About Insurance and Medicine
What medications should you bring, what insurance do you need and how do you find a doctor? Here are health care tips if you’re traveling internationally.
-
Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.
-
Bipartisan Lawmakers Seek to Break Up Giant Health Care Conglomerates
New legislation would force UnitedHealth Group, CVS Health and Cigna to each sell their pharmacies within three years.
-
Opioids Ravaged a Kentucky Town. Then Rehab Became Its Business.
In Louisa, an unbearable social crisis has become the main source of economic opportunity.
-
Acadia Healthcare’s Methadone Clinics Face Fraud Complaints
Acadia Healthcare falsifies records at its methadone clinics and enrolls patients who aren’t addicted to opioids, a Times investigation found.
-
‘Delay, Deny, Defend’: United Has Faced Scrutiny Over Denying Claims
The company has been accused of using algorithms to deny treatments and refusing coverage of nursing care to stroke patients.
-
After UnitedHealthcare CEO’s Killing, Americans Express Frustration With Health Insurance Industry
The shooting death of a UnitedHealthcare executive in Manhattan has unleashed Americans’ frustrations with an industry that often denies coverage and reimbursement for medical claims.
-
Brian Thompson, Health Insurance Executive, Dies at 50
He was “a truly extraordinary person who touched the lives of countless people,” the chief executive of UnitedHealth Group said.
-
Who Is Brian Thompson?
Mr. Thompson managed a division that employs about 140,000 people and offers insurance plans to employers and individuals.
-
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.